SCHEMBL24832200

SCHEMBL24832200

c1ccc(N(c2ccccc2)c2ccc3c(c2)-c2cc4ccccc4c4cccc-3c24)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
HSD17B10 Q99714 5/20 0.65
TSHR P16473 3/20 0.65
MAPK1 P28482 3/20 0.65
HPGD P15428 3/20 0.65
HIF1A Q16665 3/20 0.65
CASP1 P29466 3/20 0.65
L3MBTL1 Q9Y468 3/20 0.65
CASP7 P55210 2/20 0.41
TP53 P04637 1/20 0.41
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
CYP1A2 P05177 4/20 0.37
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16484565 0.89 ALDH1A1 (0.51) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL24079012 0.86 ALDH1A1 (0.45) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL19998697 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL16484567 0.84 ALDH1A1 (0.51) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL15097043 0.84 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL24079013 0.83 ALDH1A1 (0.49) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL6395307 0.83 AKR1C3 (0.40) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL4599628 0.82 ALDH1A1 (0.42) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL12236527 0.82 ALDH1A1 (0.60) ALDH1A1HSD17B10TSHRMAPK1HPGD
SCHEMBL23281054 0.81 CYP11B1 (0.41) ALDH1A1HSD17B10TSHRMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230051889-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-16 US disclosed
EP-4112601-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2023-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230051889-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, COG1, CRY2 ALDH1A1 1585/4885HSD17B10 2753/4885TSHR 4145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.